Eisai Pharmaceuticals India Private Limited
Products
Profile
What they make
About
Eisai Pharmaceuticals India Pvt. Ltd. is a subsidiary of Japanese pharmaceutical company Eisai Co., Ltd. based in Tokyo, India.
Leadership team
Locations
Registry records
These are entries in government registers. BharatSeal has not checked them separately.
Record completeness: 4 of 7 records on file
More company facts
What we checked, and when
7 facts · 0 checked · 4 on record or declared · 3 unknown
Checks confirm records. They do not prove quality or delivery.
Identity and registrations4 on record or declared · 3 unknown
Company registration (CIN)U24232AP2007PTC053247On record in MCADetails
- Source
- MCA
- Method
- Read from the public register file
- Date checked
- Not checked by BharatSeal
- Next check
- No check scheduled
- What this does not prove
- A company registration does not prove the company trades or manufactures.
- CIN
- U24232AP2007PTC053247
Active status in MCAOn record in MCADetails
- Source
- MCA
- Method
- Read from the public register file
- Date checked
- Not checked by BharatSeal
- Next check
- No check scheduled
- What this does not prove
- An active status does not prove filings are current.
GST registrationNot found in GST network (this proves nothing on its own)Details
- Status
- Ask about this in your enquiry.
Udyam registration (MSME)Not found in Udyam (this proves nothing on its own)Details
- Status
- Ask about this in your enquiry.
Income-tax PANNot found in Income Tax (this proves nothing on its own)Details
- Status
- Ask about this in your enquiry.
Paid-up capitalOn record in MCADetails
- Source
- MCA
- Method
- Read from the public register file
- Date checked
- Not checked by BharatSeal
- Next check
- No check scheduled
- What this does not prove
- Capital on paper does not prove cash in the business.
Date of incorporationOn record in MCADetails
- Source
- MCA
- Method
- Read from the public register file
- Date checked
- Not checked by BharatSeal
- Next check
- No check scheduled
- What this does not prove
- An old incorporation date does not prove the company has been operating since.
Payment terms and the 45-day rule
Not on record
TReDS is the RBI-regulated system where MSMEs sell unpaid invoices. BharatSeal has no arrangement with any operator and passes them no data.
C2tredsDTXInvoicemartM1xchangeRXIL
This states the law as written. It is not legal or tax advice.
About EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED
EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED is a manufacturer of pharma based in Anakapalli, Andhra Pradesh, India. It was incorporated in 2007 per Ministry of Corporate Affairs records (CIN U24232AP2007PTC053247). It is on record in MCA, official Indian government registers. EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED has not claimed its BharatSeal profile.
Frequently asked questions
What does EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED manufacture?
Manufacturing (Metals and Chemicals, and products thereof)
Where is EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED located?
Anakapalli, AP, India
Is EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED verified on BharatSeal?
No. EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED has not claimed its BharatSeal profile. Registry records on this page are on record in government registers; BharatSeal has not checked them separately.
When was EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED founded?
EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED was incorporated in 2007 per Ministry of Corporate Affairs records under CIN U24232AP2007PTC053247. The company has been operating for 19 years, with the registration auditable on mca.gov.in.
Who are the directors of EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED?
EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED's current directors include Takuya Kijima, Girish Dixit. Director records are sourced from the MCA21 corporate registry and reflect the latest filing with the Ministry of Corporate Affairs.
How do I contact EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED?
Send an enquiry through BharatSeal. Every enquiry is logged so you have a record of the conversation.